NH Nongwoobio Co., Ltd. (KOSDAQ:054050)

NH Nongwoobio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-0	-	-	-	0
Revenue	151,034	144,680	135,844	133,400	132,843	130,030
Revenue Growth (YoY)	5.23%	6.50%	1.83%	0.42%	2.16%	7.23%
Cost of Revenue	75,612	73,687	70,426	68,630	70,334	71,075
Gross Profit	75,422	70,994	65,417	64,770	62,509	58,955
Selling, General & Admin	40,562	38,605	36,096	33,730	35,409	35,148
Research & Development	17,965	17,770	17,375	17,198	17,150	16,919
Amortization of Goodwill & Intangibles	276	279	231	230	340	123
Other Operating Expenses	925	867	623	584	697	651
Operating Expenses	62,991	59,891	56,473	53,639	55,685	54,760
Operating Income	12,431	11,103	8,945	11,131	6,824	4,195
Interest Expense	-990.03	-1,027	-1,385	-1,246	-973	-977
Interest & Investment Income	1,084	862	593	385	212	186
Earnings From Equity Investments	-	-	-	-	-	-10
Currency Exchange Gain (Loss)	1,065	3,591	634.66	262.86	1,740	-2,141
Other Non Operating Income (Expenses)	803.34	-716.37	991.93	1,184	859.36	1,715
EBT Excluding Unusual Items	14,393	13,813	9,779	11,717	8,662	2,968
Gain (Loss) on Sale of Assets	2,079	236	1,016	523	64	4,802
Asset Writedown	-583	-583	-815	-1,428	-1,145	-
Pretax Income	15,889	13,466	9,980	10,812	7,581	7,770
Income Tax Expense	2,778	2,557	-188.24	925.86	628.17	-1,687
Earnings From Continuing Operations	13,111	10,909	10,169	9,886	6,953	9,456
Earnings From Discontinued Operations	-	-	152.77	-64.97	-	-
Net Income to Company	13,111	10,909	10,321	9,821	6,953	9,456
Minority Interest in Earnings	14.5	-69.6	11.24	57.54	-22.91	-56.41
Net Income	13,125	10,839	10,333	9,879	6,930	9,400
Net Income to Common	13,125	10,839	10,333	9,879	6,930	9,400
Net Income Growth	27.11%	4.90%	4.59%	42.54%	-26.27%	34.58%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	0.08%	-	-	-	-	-
EPS (Basic)	818.28	676.17	644.56	616.24	432.32	586.36
EPS (Diluted)	818.28	676.17	644.56	616.24	432.00	586.00
EPS Growth	27.00%	4.90%	4.59%	42.65%	-26.28%	34.50%
Free Cash Flow	6,423	11,402	10,197	5,066	167.19	2,080
Free Cash Flow Per Share	400.45	711.24	636.10	316.05	10.43	129.78
Dividend Per Share	220.000	220.000	200.000	200.000	200.000	200.000
Dividend Growth	10.00%	10.00%	-	-	-	-
Gross Margin	49.94%	49.07%	48.16%	48.55%	47.05%	45.34%
Operating Margin	8.23%	7.67%	6.59%	8.34%	5.14%	3.23%
Profit Margin	8.69%	7.49%	7.61%	7.41%	5.22%	7.23%
Free Cash Flow Margin	4.25%	7.88%	7.51%	3.80%	0.13%	1.60%
EBITDA	19,004	17,308	14,318	17,101	13,732	10,916
EBITDA Margin	12.58%	11.96%	10.54%	12.82%	10.34%	8.39%
D&A For EBITDA	6,573	6,205	5,374	5,970	6,908	6,721
EBIT	12,431	11,103	8,945	11,131	6,824	4,195
EBIT Margin	8.23%	7.67%	6.59%	8.34%	5.14%	3.23%
Effective Tax Rate	17.49%	18.99%	-	8.56%	8.29%	-
Advertising Expenses	-	992	970	937	1,442	2,115

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.